Greatech Technology Berhad has entered into a memorandum of understanding in relation to the proposed acquisition of 60% equity interest in Kaon Automation Limited.
According to CEO Dato Tan Eng Kee, Kaon Automation brings along a big pool of highly skilled professional expertise with futuristic technology in delivering transformational solutions. In the life science aspect, it specialises in pharmaceutical and medical devices industries which includes having vast experience in meeting the stringent requirements of the world-class standard.
“With the combined solid expertise from Kaon Automation and Greatech, this will leverage the strengths of the two companies both in the business aspect as well as in the internal cohesiveness environment. I trust that greater synergy for longer business sustainability will derive from this strong partnership”, said Dato’ Tan.
The Irish medical technology sector is recognised as being the top five global hubs and is reputable for world-class expertise with excellent research centers and initiatives. On top of that, the hallmark of the Irish people and their warm culture will influence and drive an incremental value chain to the organization holistically. With this pursuit, technology and cultural integration will shape and transform our market outreach while exposing our talents to globalization, leading our team to aim far and soar high”, continued Dato’ Tan Eng Kee.
“I trust with this notable engagement, Greatech is accelerating itself into a new defining moment, promising a more exciting adventure to come”, concluded the CEO
